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REKABENTUK, SINTESIS, AKTIVITI SITOTOKSIK DAN               
INTERKALASI DNA BAGI TERBITAN β-KARBOLINA BARU 
 
ABSTRAK 
Fokus kajian ini adalah untuk menyelidik tentang kesan sitotoksik in vitro 
terbitan baru β-karbolina terhadap sel kanser manusia K562. Analisis menggunakan 
model 3D-QSAR telah mendedahkan kepentingan penukargantian pada posisi-2 dan 
-9 β-karbolina. Dua siri baru terbitan N2-benzil-β-karbolina (M23-M46) dan N2-N9-
benzil-1-tertukarganti-β-karbolina (M47-M113) telah disintesis dan dicirikan 
menggunakan tindak balas empat langkah telah memberikan hasil yang baik (>70%). 
Sebatian M23-M113 menunjukkan aktiviti antikanser yang paling kuat dengan nilai 
IC50 antara 0.01-4 μM, kecuali sebatian M88-M90 dengan nilai IC50 lebih daripada 
100 μM. Enam daripada terbitan N2-N9-benzil-1-tertukarganti-β-karbolina (M53, 
M85, M86, M104, M109 dan M112) menunjukkan nilai IC50 antara 0.01-0.07 μM 
berbanding Doxorubicin (DOX) yang digunakan sebagai kawalan positif (0.77 μM). 
Kajian hubungan struktur-aktiviti (SAR) mendedahkan bahawa penukargantian 
tambahan kumpulan benzil pada posisi-2 dan -9 menunjukkan aktiviti sitotoksik 
yang paling menarik. Agen interkalasi seperti DOX, harmine (HAR), 5-fluorouracil 
(5-FU) dan terbitan β-karbolina yang terpilih, M53 dan M56 digunakan sebagai 
sebatian model. Mekanisme interkalator telah diterokai menggunakan DNA timus 
anak lembu (CT-DNA) sebagai sistem model. UV-Vis menunjukkan bahawa DOX, 
HAR, M53 dan M56 mendorong kesan hipokromik dan anjakan merah, sementara  
5-FU tidak. Dalam pemancaran pendarfluor, pelindapkejutan pendarfluor telah 
diperhatikan dalam sistem EtBr-DNA (siasatan) dengan penambahan DOX, HAR,  
5-FU, M53 dan M56. Dalam dikroisme bulat, DOX dan HAR mengubah keamatan 
xxvi 
 
jalur positif dan negatif DNA dalam arah yang sama manakala sebatian M53 dan 
M56 mencetuskan perubahan yang bertentangan. Pengikatan DOX, HAR, M53 and 
M56 dengan DNA adalah secara mod interkalasi. Dalam kajian in silico, sebatian 
M53 dan M56 telah didok ke d(CGATCG)2 oligonukleotides yang diambil dari Bank 
Data Protein (PDB ID: 1D12) sebagai wakil model interaksi antara agen antikanser 
dan DNA melalui mod interkalasi. Kajian eksperimen dan in-silico saling 
dipersetujui di mana kedua-duanya membuktikan bahawa sebatian M53 dan M56 
terikat kepada DNA secara interkalasi antara pasangan asas CG. 
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DESIGN, SYNTHESIS, CYTOTOXIC ACTIVITY AND DNA 
INTERCALATION OF NEW β-CARBOLINE DERIVATIVES 
 
ABSTRACT 
The focus of this study has been to investigate the in vitro cytotoxic effects of 
new β-carboline derivatives on the K562 human cancer cell line. Analysis using 3D-
QSAR models has revealed the importance of derivatisation at position-2 and -9 of 
the β-carbolines. Two new series of N2-benzylated-β-carboline (M23-M46) and     
N2-N9-benzylated-1-substituted-β-carboline derivatives (M47-M113) were 
synthesised and characterised using four-step reaction and were produced in good 
yields (>70%). Compounds M23-M113 exhibited the most potent anticancer activity 
with IC50 values between 0.01-4 µM, except for compounds M88-M90 which 
produced IC50 values of more than 100 µM. Six of N
2-N9-benzylated-1-substituted-β-
carboline derivatives (M53, M85, M86, M104, M109 and M112) showed IC50 
values between 0.01-0.07 µM when compared to doxorubicin (DOX) which was 
employed as the positive control (0.77 µM). The structure-activity relationships 
(SARs) study has revealed that additional substituents of the benzyl group at 
position-2 and -9 exhibited the most interesting cytotoxic activities. Intercalator 
agents such as DOX, harmine (HAR), 5-fluorouracil (5-FU) and selected -carboline 
derivatives M53 and M56 were used as the model compounds. The intercalating 
mechanism was explored using calf thymus DNA (CT-DNA) as a model system. 
UV-Vis showed that DOX, HAR, M53 and M56 induced hypochromic effect and 
redshift, while 5-FU did not. In fluorescence emission, fluorescence quenching was 
observed in the EtBr-DNA system (probe) upon addition of DOX, HAR, 5-FU, M53 
and M56. In circular dichroism (CD), DOX and HAR changed the intensities of the 
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positive and negative bands of DNA in the same direction while compounds M53 
and M56 induced the opposite change. The binding of DOX, HAR M53 and M56 
with DNA was through the intercalation mode. In the in-silico study, compounds 
M53 and M56 were docked onto d(CGATCG)2 oligonucleotides retrieved from the 
Protein Data Bank (PDB ID: 1D12) as the representative of the interaction model 
through intercalation mode between anticancer agents and DNA. The experimental 
and in-silico studies were in good agreement whereby both proved that compounds 
M53 and M56 were bound to DNA via intercalation between CG base pairs. 
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CHAPTER 1 
 
INTRODUCTION 
 
1.1 Cancer 
Cancer, an illness that has haunted mankind and will continue to be a major health 
issue, can be defined as a collection of diseases characterised by uncontrolled cell 
proliferation leading to dissemination (metastasis) to other parts of the body 
eventually compromising normal body function. The spread of the primary growth to 
secondary locations distinguishes cancer from benign tumours making its eradication 
far more difficult.  
 As far as the Malaysian community is concerned, the incidence of cancer 
increased from 32,000 cases in 2008 to 37,400 in 2012. This number is predicted to 
rise to 56,932 by 2025 if no action is taken (The Star Online, 2014). According to the 
International Agency for Research on Cancer (IARC), which is under World Health 
Organisation (WHO), and through their Globocan project, death due to cancer 
(cancer mortality) was 20,100 in 2008 and had increased to 21,700 in 2012. Based on 
statistics released by Globocan 2012, cancer cases worldwide are forecast to rise by 
75% and reach close to 25 million over the next two decades (Ferlay et al., 2014; The 
Star Online, 2014). It is believed that some races are genetically predisposed to 
particular types of cancer while incidence rates depend on environmental factors 
such as diet and lifestyle (National Cancer Institute, 2015). 
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 Carcinogenesis, the process leading to cancer formation, is complicated and 
not yet fully understood and often involves phenotypic alterations that give cancer 
cells a selective advantage for growth over normal cells. These may include over 
competitive behaviour for growth factors, over-production of intercellular growth 
signals or errors in genes which regulate programmed cell death (apoptosis). This is 
usually accompanied by modifications which enable cells to invade surrounding 
tissue and metastasize to other parts of the body to form new tumours (King, 1996). 
 The prognosis for patients treated at the early stages of this malady is 
invariably better due to the smaller number and less destructive nature of a tumour. 
Surgery is the usual starting point for treatment of solid tumours followed by 
radiation therapy and chemotherapy depending on the site and nature of the disease. 
As a majority of tumour cells have a higher proportion of dividing cells as compared 
to normal tissue, they are more susceptible to the lethal effect of chemotherapeutic 
agents. However, rapidly dividing normal cells, such as those of the bone marrow, 
digestive tract and hair follicles are also affected causing unwanted side effects such 
as myelosuppression, vomiting, gastrointestinal disturbances and alopecia (Han et al., 
2017). This poses limitations on the dose of a particular drug that can be 
administered, which in turn reduces the effect of the treatment. 
 The problem of systemic toxicity has been partially alleviated by combination 
therapy which usually involves the administration of two or three cytotoxic agents 
with different mechanisms of action, such as topoisomerase inhibitors, 
antimetabolites, and alkylating agents (Tacar et al., 2012). This strategy also 
enhances overall tumour cell destruction but rarely eradicates all the cells. The small 
clone and progenitor cells which survive treatment frequently redivide to form a new, 
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drug-resistant tumour. Unfortunately, this means that except for prostate cancer, 
Hodgkin’s lymphoma and childhood leukaemia, the disease is often fatal.  
 As a consequence, extensive research is being carried out to find new drugs 
that overcome the problems of toxicity and resistance associated with chemotherapy. 
Many of these are based on compounds already in clinical use. 
 
1.2 DNA intercalating agents 
Among the agents currently used in the treatment of cancer are the DNA 
intercalating agents. These possess a polycyclic aromatic ring system that allows 
reversible non-covalent interdigitation between adjacent base pairs in the 
hydrophobic interior of the DNA double helix (Lerman, 1961). The impact would be 
a local distortion and an overall lengthening of the DNA helix as it unwinds to 
accommodate the drug molecule (Waring, 1979; Reinert, 1983) (Figure 1.1). 
Compounds with tri-and tetracyclic chromophores which are approximately of the 
same dimension as the purine-pyrimidine base pairs usually show optimal binding.  
 
Figure 1.1: Intercalation of ethidium bromide (EtBr) into-double-stranded DNA, 
showing lengthening of the DNA helix (reproduced from Watson, 1987) 
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In some cases, the drug may contain additional constituents attached to the 
chromophore which strengthens intercalation by interacting with the anionically 
charge DNA phosphate backbone (Foye et al., 1982; Pachter et al., 1982; Pohle et al., 
1990). However, this type of binding is much weaker than intercalation because it 
occurs on the exterior surface of the DNA helix and is influenced to no small extent 
by the conditions of the surrounding medium (Jones et al., 1980). 
 
1.2.1 The anthracycline antitumor agents 
Anthracycline antibiotics such as doxorubicin (DOX) were isolated from 
Streptomyces bacterium (Streptomyces peucetius var caesius) in the 1960s (Chen et 
al., 1999). DOX still among the most widely and active chemotherapeutic agents in 
use (Lown, 1993; Iwaki et al., 2000; Minotti et al., 2004; Peng et al., 2005).  
 Chemically, the anthracyclines contain an amino sugar attached to an 
aglycone ring, the latter consisting of a non-aromatic (A) ring conjugated with an 
anthraquinone moiety (Figure 1.2). DOX can also be used alone or in combination to 
treat a wide range of cancers including acute leukaemias, Hodgkin's and non-
Hodgkin's lymphomas, cancers of the bladder, stomach, breast, lung, thyroid, 
ovaries, soft tissue, bone sarcomas, multiple myelomas, and others (Rebecca et al., 
2017).  
 
Figure 1.2: The antitumor anthracycline doxorubicin 
A 
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 The principal mode of action of the anthracyclines is thought to be mediated 
through intercalation of the aglycone portion of the molecule between adjacent DNA 
base pairs (Takahashi & Naganuma, 2017). DOX interacts with DNA on a molecular 
level by intercalation and destruction of macromolecular biosynthesis. This inhibits 
the function of enzyme topoisomerase II which is involved in the unwinding of 
supercoiling of DNA for transcription. DOX stabilises the topoisomerase II complex 
after it has fragmented the DNA strand for replication preventing the DNA double 
helix from being re-sealed thereby stopping the replication process. The aromatic 
chromophore of the molecule intercalates between the base pairs of the DNA, while 
the six-membered daunosamine sugar is placed in the minor groove and interacts 
with flanking base pairs together to the intercalation site (Box, 2007). As a result of 
the highly undesirable features associated with the use of the anthracyclines in 
chemotherapy, a lot of time and effort has been devoted to developing derivatives of 
DOX in the hope of enhancing antitumor activity and lowering the side effects.  
 In order to elucidate the desired biological activity, the structure of a drug 
should be complementary with the receptor. However, due to the complex nature of 
the biological systems, the predicted effect of the structural fluctuations in the 
biological activity of the drug is uncertain (Shah et al., 2010). Therefore, extensive 
research is an important pre-requisite for the determination of structure-activity 
relationship (SAR) and the significance of structural modification. With this in mind, 
new anticancer agents, β-carbolines, were evaluated for their drug-DNA binding. 
 In recent years, β-carboline derivatives have been reported to have excellent 
anticancer drug properties. Their ability to act as DNA intercalating agents is related 
to their potent antitumor activities (Rescifina et al., 2014; Zhang & Sun, 2015; 
Kumar et al., 2017). Among the β-carboline derivatives, the most represented 
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naturally occurring β-carboline alkaloid endowed with antitumor properties is 
harmine (HAR) or 7-methoxy-1-methyl-9H-pyrido[3,4-b]indole (Figure 1.3). HAR is 
capable of inducing DNA single or double strand breaks (Boeira et al., 2002). 
Recently, derivatives of HAR have come into focus as they can inhibit various 
cancer cell lines in nanomolar concentrations (Meinguet et al., 2015; Geng et al., 
2018).  
 
Figure 1.3: The chemical structure of harmine 
 
1.3 Problem statement 
Inspired by cytotoxic potential of β-carboline derivatives against various cancer cell 
lines (Cao et al., 2010; 2013; Zhang et al., 2013), a series of new β-carboline 
derivatives were designed, synthesised, and screened for their in vitro cytotoxic 
strength. 
 Previous studies have reported more complicated synthesis route for the        
β-carboline derivatives with structural requirements for position-2 and -9 (Zhang et 
al., 2013). Therefore, the present study has been streamlined to develop a more 
straightforward, less time consuming and cost-effective synthesis route. This 
synthesis process is challenging especially when it comes to completing 
aromatization under oxidative conditions and β-carbolineum salt reactions for 
generating a high yield of β-carboline derivatives. Although the cytotoxic potency at 
various positions has been explored extensively over the years, synthesis of 
derivatives with such structural requirements at position-2 and -9 in the one-pot 
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reaction has not been investigated thus far. Benefits of this reaction include time, cost 
and labour efficiencies.  
 For the cytotoxicity studies, literature has reported anticancer potential of      
β-carboline against many in vitro cell lines such as BGC-823, MCF-7, 22RV1, 
HepG2, 769-P, HT-29, A375, SK-OV-3, Eca-109 and LLC (Zhang et al., 2013). The 
current study will focus on the structural requirements of β-carboline derivatives at 
position-2 and -9 for the cytotoxic activity against the K562 cell line. K562 is human 
immortalised myelogenous leukemia (CML) cell line. There is no cytotoxic activity 
of β-carboline against K562 has been reported. Therefore, this study is the first of its 
kind to indicate the structural relationship between β-carboline derivatives and K562 
cells. In addition, the orientation of β-carboline derivatives that bind to the DNA 
complex will also be studied. The interactions between β-carboline derivatives and 
DNA will be studied using various spectrophotometric methods. In order to 
understand the molecular interaction with its macromolecular target, molecular 
docking technique will be used to provide molecular interaction information between 
β-carbolines and DNA.  
 
1.4 Scope of study 
The primary goal of this research is to design and synthesise new β-carboline 
derivatives library and to elucidate their antitumor structure-activity relationships 
(SARs). It is essential to use inexpensive starting materials with minimal usage of 
chromatography and less reaction steps in the synthesis. In the present study, 
exploration of the cytotoxic potential of β-carboline derivatives having substituents 
at position-2 and -9 positions was undertaken using 3D-QSAR studies.  
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 The new β-carboline derivatives were produced by the positional 
modification of benzyl substituent moieties at position-2 and -9. This amendment 
may be the key for the modulation of cytotoxic strength. The mechanism of action of 
the compounds via DNA binding interactions was analyzed using several analytical 
procedures including thermal melting denaturation, UV-Visible absorption 
spectroscopy, fluorescence emission spectroscopy and circular dichroism coupled 
with the computational technique of molecular docking. 
 
1.5 Objectives  
Based on the importance of β-carboline, the objectives of this study are listed below: 
i. To understand structural requirement for various positions of β-carboline 
scaffold as potent cytotoxic agents using 3D-QSAR model developments 
using literature data. 
ii. To synthesise, characterise and evaluate various β-carboline derivatives 
against human chronic myelogenous leukaemia (CML) cancer cell (K562) 
and mouse embryonic fibroblast BALB/3T3 clone A31 non-cancer cell line 
cytotoxic activities. 
iii. To investigate the interaction between selected β-carboline derivatives and 
DNA.  
 
 
 
 
 
 
 
9 
 
CHAPTER 2 
 
LITERATURE REVIEW 
 
2.1 Background of β-carboline 
β-Carboline derivatives display a broad range of significant biological activities 
(King et al., 2000; Arzel et al., 2001; Chen et al., 2009) and their saturated 
derivatives are a common nucleus in various natural products (Edwanker, 2009).     
β-Carboline has a common planar tricyclic pyrido[3,4-b]indole ring system that 
belongs to the group of indole alkaloids consisting of a pyridine ring that is bonded 
to an indole skeleton (Abramovitch & Spencer, 1964; Allen & Holmstedt, 1980).  
 Consequently, a substitute β-carboline, 9H-pyrido[3,4-b]indole - also known 
as norharman (1) has been identified as mentioned by IUPAC. The structure of        
β-carboline is similar to tryptamine with the ethylamine chain connected to the 
indole ring, producing a three-ringed structure. The structure and the numbering of 
the β-carboline skeleton are shown in Figure 2.1. 
 
Figure 2.1: Numbering of the β-carboline (1) skeleton 
 
 The first β-carboline alkaloid known as harmaline (5), was initially isolated in 
1841 from Peganum harmala (Zygophyllaceae, Syrian rue) (Figure 2.2). In North 
Africa and the Middle East, it is used as an emmenagogue and an abortifacient as 
well as a traditional herb to stimulate menstrual flow (Mahmoudian et al., 2002). In 
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the Amazon basin, plants containing β-carbolines were utilised as hallucinogenic 
snuffs or drinks. Besides, the extracts of the seeds of Peganum harmala have been 
used for hundreds of years to treat malaria and alimentary tract cancers in Northwest 
China (Chen et al., 2004; Moloudizargari et al., 2013). The roots and seeds of 
Peganum harmala contain the highest level of alkaloids with low concentrations 
being observed in the leaves and stems. In addition, there is no β-carboline alkaloid 
in the flowers (Lamchouri, 2014). 
 
Figure 2.2: Peganum harmala (adapted from Asgarpanah & Ramenzanloo, 2012)  
 
 The occurrence of β-carbolines in nature is widespread presumably due to the 
simple biogenesis of tryptamine (or tryptophan). During the last two decades, 
numerous β-carboline alkaloids with saturated and unsaturated tricyclic ring systems 
have been revealed from various plants, marine creatures, insects, foodstuff and 
mammals. This also includes body fluids and human tissues as major bioactive 
constituents (Airaksinen & Kari, 1981; Karin et al., 1990; Saxton, 1998; Carbrera & 
Seldes, 1999; Kawasaki & Higuchi, 2005; Cao et al., 2007; Higuchi & Kawasaki, 
2007; Mansoor et al., 2009; Gonzalez-Gomez et al., 2009).  
 β-Carbolines can be categorised according to the degree of saturation of their 
N-containing six-membered pyridine ring. Unsaturated members are fully aromatic 
11 
 
β-carbolines such as norharman (1), harman (2), harmine (3) and harmol (4), whereas 
dihydro-β-carbolines (DHβCs) such as harmaline (5), harmalol (6) and harmalan (7) 
have partially saturated ring (Figure 2.3). Fully saturated members are known as 
tetrahydro-β-carboline (THβC) such as compound 8 (Figure 2.3) (Cao, et al., 2007). 
The tricyclic β-carbolines usually contain several substituents both in the N-
containing six-membered pyrido ring and the indole ring. The so-called Pictet-
Spengler condensation reaction of indoleethylamines or tryptophan with an aldehyde 
or α-keto acids has been confirmed to be the most efficient route for the chemical 
synthesis of THβCs or tetrahydro-β-carboline-3-carboxylic acids (THβCAs) (Cao et 
al., 2007). They showed unique three-dimensional arrangements of the chiral 
functional groups exhibiting specificity in the protein binding and eliciting a specific 
biological response. The rings are often referred to as A-, B-, and C-ring, as labelled 
in structure 1 (Figure 2.3).  
 The presence of two kinds of nitrogen (-N and -NH) in β-carbolines, pyridinic 
nitrogen and the less crucial pyrrolic nitrogen, affects the photophysical and 
photochemical properties of the alkaloids. The basicity of pyrrolic nitrogen increases 
upon excitation (Dias et al., 1992; Carmona et al., 2000) and is also affected by the 
substitutions in the tricyclic structure (Hidalgo et al., 1990).  Depending on the pH 
and solvent employed, β-carbolines can exist in four forms; cationic, neutral, anionic 
and zwitterion (or alternative quinine-type canonical formula) (Varela et al., 2001). 
12 
 
 
Figure 2.3: Structures of β-carbolines (1, 2, 3 and 4), dihydro-β-carbolines (DHβCs) 
(5, 6 and 7) and tetrahydro-β-carboline (THβC) (8) alkaloids 
 
 β-Carbolines are of great interest due to their broad spectrum of biochemical 
effects and pharmacological properties. Numerous reports showed β-carboline 
alkaloids effect the central nervous system (CNS) such as benzodiazepine receptors, 
5-HT2A and 5-HT2C receptors (Brierly & Davidson, 2012; Herrick-Davis et al., 2015; 
Phipps & Grundmann, 2017). Other researches focused on the antitumor activity of 
β-carbolines. Various reports suggested β-carbolines demonstrate potent antitumor 
activities (Cao et al., 2013; Zhang et al., 2013). The cytotoxic activity correlates with 
both the planarity of the molecule and the presence of the ring substituents 
(Chourasiya et al., 2016). Multiple mechanisms have been suggested for their 
antitumor activity such as intercalating into DNA (Hayashi et al., 1977), inhibiting 
topoisomerase I and II (Deveau et al., 2001), cyclin-dependent kinase (CDK) (Song 
et al., 2002; 2004), and IKK (I-Kappa-B kinase) (Castro et al., 2003). 
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2.2 Synthesis of β-carboline derivatives  
Several synthesis methods aimed at displaying the biological activities of β-carboline 
derivatives have been reported (Snyder et al., 1948; Brossi et al., 1973; Bobbitt & 
Willis, 1980; Lippke et al., 1983; Ishida et al., 1999; Cao et al., 2004; 2005a; 2008; 
2010a; Guan et al., 2006; Wu et al., 2009a; 2009b; Meesala et al., 2014; Kamal et al., 
2015a; 2015b). Their importance has demanded efficient synthesis methods for 
constructing heterocyclic systems and their functionalization. The most efficient and 
rapid routes for the construction of the β-carboline moiety include the intramolecular 
Friedel-Crafts reactions such as Pictet-Spengler and Bischeler-Napieralski reaction 
followed by esterification, aromatization or decarboxylation and N-alkylation or     
N-benzylation.  
 
2.2.1 Precursors in the synthesis of β-carbolines 
Tryptophan (9) and its decarboxylation product tryptamine (10) (Figure 2.4) are two 
primary precursors usually used in the construction of β-carboline skeleton (Love, 
2006; Domínguez & Pérez-Castells, 2011). A recent study has described that indole 
(11) (Figure 2.4) is the source of the β-carboline skeleton (Kamlah et al., 2016). 
 
Figure 2.4:  Precursors used in the synthesis of β-carbolines 
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2.2.2 Conventional synthetic methods of β-carbolines 
Pictet-Spengler and Bischeler-Napieralski condensations are the two conventional 
methods used to synthesise β-carbolines (Love, 2006; Cao et al., 2007; Domínguez 
& Pérez-Castells, 2011). However, these two well-known procedures do not lead 
directly to the entirely aromatic β-carbolines (1) but through tetrahydro- (8) or 
dihydro-β-carboline derivatives (12), as illustrated in Scheme 2.1.  
 
Scheme 2.1: Summary of conventional synthetic methods of β-carbolines (1) 
 
 The Pictet-Spengler reaction which was first discovered in 1911 by Ame 
Pictet and Theodor Spengler has been the crucial procedure in generating either 
substituted or fused β-carbolines (Pictet & Spengler, 1911; Cox & Cook, 1995). It 
consists of the condensation of indole ethylamine such as tryptamine (10) (or 
tryptophan, 9) with an aldehyde or another electrophile. The reaction of THβCs 
proceeds through a spiro-indolenine intermediate (10b) as illustrated in Scheme 2.2, 
which collapses to form β-carbolines (1) (Cao et al., 2004).  
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Scheme 2.2: Mechanism reaction of compound 8 using Pictet-Spengler reaction  
 
 Nucleophilic aromatic rings such as indole or pyrrole have given products 
with excellent yields under mild conditions while the less nucleophilic aromatic rings 
such as benzene or indoles with electron withdrawing substituents on the benzene 
ring have exhibited poor yields even under harsh conditions. The electrophilic 
substitution at position-2 by indole gave the five-membered ring intermediate (10b) 
which then rearranged to form a six-membered ring (10c). Deprotonation gave the 
desired product of THβC (8) (Larghi et al., 2005). The electrophilicity of the imine 
double bond works as the driving force for the cyclisation (Scheme 2.2). The reaction 
occurs readily in mild condition which is temperature- and pH-dependent. 
Aromatization to the desired β-carbolines (1) can be accomplished by the oxidation 
of THβC (8). 
 Bischeler-Napieralski reaction is an intramolecular electrophilic aromatic 
substitution reaction that allows the cyclisation of β-arylethylamides. It was first 
discovered in 1893, by August Bischler and Bernard Napieralski. This result is 
similar to the Pictet-Spengler reaction but differs in the fact that tryptamine (10) is 
first acylated to give amide (11) (Scheme 2.3). The latter is dehydrated to an active 
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iminium species which is then cyclised to provide DHβC (12). The common 
dehydration reagents used were PCl5, POCl3, SOCl2 or ZnCl2 for the removal of the 
carbonyl oxygen. Even though the oxidation step of the DHβC (12) is much easier to 
achieve than THβC (8) the dehydration step requires vigorous reaction conditions 
which restrict the use of this method. 
 
Scheme 2.3: A Bischler-Napieralski cyclisation and reduction of DHβC (12) 
 
2.2.3 The aromatization of β-carbolines system 
The Pictet-Spengler reaction allows for the construction of a THBC core with 
appropriate substitution which could be extended after the cyclisation or the 
installation of different changes, undergoing cascade reactions during cyclisation to 
afford new THBC derivatives. These THBCs can then be oxidised to generate the 
desired β-carboline derivatives.  
 However, alternative strategies to create β-carbolines can also be 
accomplished by using a variety of reagents (Love, 1996). A few reactions have been 
conducted by heating the substrate with palladium on carbon (Soerens et al., 1979; 
Coutts et al., 1984; Hibino et al., 1985), sulphur in refluxing cumene or xylenes 
(Cain et al., 1982; Cao et al., 2004; Wu et al., 2009a; Qifeng et al., 2009), and 
potassium dichromate over the extended reaction time (Zhang et al., 2013). Other 
oxidising agents such as selenium dioxide (Gatta & Mitisi, 1987; Cain et al., 1983) 
and manganese dioxide (Dantale & Soderberg, 2003) were often used in excess. 
These organic-based reagents affect such dehydrogenation limiting the choice to only 
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the quinone-derived reagents such as chloranil (Snyder et al., 1948; Lippke et al., 
1983), 2,3-dichloro-5,6-dicyano-1,4-benzoquinone and DDQ (Kobayashi et al., 
1990; Yeun-Mun & Hamann, 2007) with low yields (< 30%).  
 A more efficient method for the synthesis of β-carbolines employing one-pot 
tandem β-elimination and aromatization reactions has been developed (Dong et al., 
2010). The plausible mechanism for the one-pot conversion is shown in Scheme 2.4 
converting N-tosyl-THBCs (13) into β-carbolines (14) with 70-95% yields (Dong et 
al., 2010). The N-tosyl-THBCs (13) would first react with a base to form the anions 
A-1 or A-2, and these would then immediately undergo β-elimination to afford the 
dihydro intermediates B-1 or B-2 (Amos et al., 2003; Ishikawa et al., 2004; Kitahara 
et al., 2008). The dihydro intermediates, B-1 or B-2, would then be oxidized in situ 
by molecular oxygen in the air to give the final product of β-carbolines (14) 
(Previero et al., 1984). The reaction pathways would be governed by the acidities of 
the protons on C-1 and C-3, whereby if the proton on C-1 was more acidic, then 
Path A would be preferred, whereas if the proton on C-3 were more acidic, Path B 
would be preferred. 
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Scheme 2.4: A plausible mechanism for the one-pot conversions of N-tosyl-THBCs 
(13) into β-carbolines (14) through tandem β-elimination and aromatization reactions  
 
Another work reported the aromatization of THβCs under different 
conditions. Panarese & Water (2010) showed that 2-iodoxybenzoic acid (IBX) is a 
convenient reagent for the dehydrogenation of THβCs (15). They applied this 
approach in the total synthesis of marine indole alkaloid Eudistomin U (17) as shown 
in Scheme 2.5 (Panarese & Water, 2010).  
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Scheme 2.5: IBX-mediated aromatization in the total synthesis of Eudistomin U (17) 
 
  Meesala et al. (2014) reported an efficient synthetic method to construct 
aromatic β-carbolines (1) from THβCAs (18) via copper(II) mediated 
decarboxylation and subsequent aromatization. Based on previous reports (Cohen & 
Schambach 1970; Goossen et al., 2007), a possible mechanism has been outlined in 
Scheme 2.6. Initially, a copper catalyst is inserted into a carboxylic acid (18) to give 
an intermediate 18a which undergoes oxidative addition to form intermediate 18b. A 
rapid reductive elimination provides the intermediate decarboxylation 18c, followed 
by protonolysis and converting it into THβCs (8), which is then transformed into the 
aromatic β-carboline (1) by oxidative aromatization.  
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Scheme 2.6: Proposed mechanism for copper-mediated decarboxylation and 
aromatization of THβCAs (18) 
 
 Kamal et al. (2015a, b) developed a simple, mild and efficient protocol for a 
one-pot reaction of a THβACs (19) to produce β-carboline (20) (Scheme 2.7). This 
employs a cost-effective or mild oxidant N-chloro-succinimide (NCS) (Kamal et al., 
2015a) and iodobenzene diacetate (Kamal et al., 2015b) (Scheme 2.8), which 
produces high yields of the desired products and is able to serve as an alternative 
method compared. 
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Scheme 2.7: A possible reaction mechanism for the decarboxylation aromatization 
of THβCs (19) 
 
 
Scheme 2.8: Synthesis of β-carbolines (20) from THβCs (21) using iodobenzene 
diacetate 
 
 To summarize the aromatization of β-carboline derivatives, a variety of 
methods have been used, but only limited forms can generate the essential                
1-substituted product. An oxidation step is also necessary to prepare the entirely 
aromatic β-carbolines from DHβCs (12). Since the oxidation of DHβC (12) is more 
facile than THβCs (8), there is a drawback in the Bischeler-Napieralski approach 
(Scheme 2.1, page 14) which needs a vigorous condition in the dehydration reaction 
leading to 8 thereby making the Pictet-Spengler reaction the most appropriate 
strategy for this project.   
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2.3 Pharmacological effects of β-carboline derivatives in vitro 
Detailed knowledge relating to the pharmacophore of a given substance enhances the 
understanding of the mechanism. It is possible to identify the features of the 
pharmacophore that increase the activity of the ligand in comparison to its 
derivatives. Several investigations have reported the effects of β-carboline alkaloids 
on the CNS. In the last decade, interest in these alkaloids was stimulated by their 
promising antitumor activities. 7-Methoxy-β-carboline scaffold, harmine (3) binds to 
DNA one hundred-fold more efficiently than harmaline (5) showing cytotoxicity and 
antitumor activities against HL-60 and K562 cells (Ishida et al., 1999; Patel et al., 
2012).  
 Ishida et al. (1999) reported that twenty-six β-carbolines were evaluated for in 
vitro cytotoxicity in a human tumour cell line panel with structural modifications at 
position-1, -2, -3, -6, -7 and -9. Harmine (3) exhibited significant activities against 
several cell lines including three drug-resistant KB sublines with various resistance 
mechanisms. α-(4-Nitrobenzylidine)-harmine (22) showed a broad cytotoxicity 
spectrum against ovarian cancer (1A9), nasopharynx (KB), osteosarcoma (SaOS-2), 
lung carcinoma (A549), melanoma cancer (SK-MEL-2), glioblastoma (U-87-MG) 
and breast cancer (MCF-7) cells with ED50 values ranging from 0.3 to 1.2 µg/mL. 
SAR analysis suggested that; (i) the introduction of an oxygenated substituent at C-7 
led to the enhanced cytotoxic activity; (ii) the length of C-7 alkoxy chain affected 
both the cytotoxicity and cell line specificity; (iii) N9-alkylated-β-carboline 
derivatives exhibited strong cytotoxic effect; (iv) C-6 brominated-β-carboline 
derivatives showed selective cytotoxic activities; (v) N2-alkylated-β-carboline 
derivatives displayed distinct cytotoxic activities; (vi) 3,4-dihydro-β-carboline 
derivatives were inactive (Ishida et al., 1999).   
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 Xiao et al. (2001) have reported that 3-substituted-β-carboline derivatives, 
23-27 showed cytotoxic activities against human tumour cell lines including HL-60, 
KB, Hela and BGC-823 and were also bound to DNA by intercalation. Compound 25 
exhibited the strongest stabilisation of CT-DNA (ΔTm = 5.7 °C), the most significant 
binding affinity (Kb = 4.503 × 10
4 M-1) as well as the lowest binding energy and 
showed high inhibition rate for HL-60 and BGC-823 cells. 
 Bis-3,4-dihydro-β-carbolines (28) and bis-β-carbolines (29) were synthesised 
and exhibited cytotoxic activity towards L-1210 cell with IC50 values less than 4 µM 
(Jiang et al., 2002). Also, 1-substituted-3,4-dihydro-β-carboline derivatives showed 
significant antitumor activities against human KB-16 and murine P-388, HT-29 and 
A-549 (Al-Allaf & Rashan, 1998). Among them, 1-(9’-ethyl-3’-carbazole)-3,4-
dihydro-β-carboline (30) exhibited the most potent cytotoxic activities against all 
tested tumour cell lines with IC50 < 0.001 ug/ml (Shen et al., 2005). It is worthy to 
note that trans-palladium(II)-harmine complexes (31) displayed remarkable 
cytotoxic activities against P-388, L-1210 and K562 cell lines with the IC50 of 0.385, 
0.385 and 0.364 µM, respectively (Al-Allaf & Rashan, 1998).  
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 Cao and co-workers previously synthesised various β-carboline derivatives by 
simple structural modifications and probed the fundamental requirement of these 
compounds for potent activity in vitro (Cao et al., 2004; 2005; 2005a; 2008). A series 
of new 9-substituted-β-carboline derivatives were synthesised from harmine (1) and 
L-tryptophan (9). Compound 32 with carboxyl and n-butyl groups at position-9 and  
-3, respectively, showed the highest antitumor effect against human tumour cell lines 
including PLA-801 with IC50 value of 92 µM, HepG2 (73 µM) and Bel-7402 (92 
µM), BGC-823 (116 µM), Hela (60 µM) and Lovo (11 µM) (Cao et al., 2004). Later, 
other series of new 1,3-bisubstituted- and 1,3,9-trisubstituted-β-carbolines were 
synthesised and evaluated for in vitro study against human tumour cell lines 
including PLA-801, HepG2, Bel-7402, BGC-823, Hela and Lovo (Cao et al., 2005a). 
1,3,9-Trisubstituted β-carboline derivatives showed higher cytotoxic activities in 
vitro than their corresponding 1,3-bisubstituted derivatives. Among all the 
synthesised compounds, 1,3,9-trisubstituted-β-carbolines (33) with a methyl group at 
position-1, ethoxycarbonyl group at position-3 and pentafluorobenzyl at position-9 
